Allergan Plc Acquires Akarna Therapeutics for $50,000,000

  • Feed Type
  • Date
  • Company Name
    Akarna Therapeutics
  • Mailing Address
    1012 Second Street Encinitas, CA 92007 USA
  • Company Description
    Akarna Therapeutics is a biopharmaceutical company developing novel small molecule therapeutics that target inflammatory and fibrotic diseases for which there is no approved treatment.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Under the terms of the agreement, Allergan acquired Akarna for an upfront cash payment of $50 million and success-based development, regulatory and sales milestones.

Trending on Xconomy